Linked Data API

Show Search Form

Search Results

100186
star this property registered interest false more like this
star this property date less than 2014-10-21more like thismore than 2014-10-21
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Patients: Safety more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, whether missed or inadequate hydrocortisone administration is included in the NHS list of Never Events. more like this
star this property tabling member constituency Oxford East more like this
star this property tabling member printed
Mr Andrew Smith more like this
star this property uin 211233 more like this
star this property answer
answer
unstar this property is ministerial correction true more like this
unstar this property date of answer less than 2014-10-28more like thisremove minimum value filter
star this property answer text <p>Missed or inadequate hydrocortisone administration is not currently included in the list of ‘never events’.</p><p> </p><p> </p><p> </p><p>We can confirm that the current list of Never Events is under review and there is a consultation underway which opened online on the 6 October 2014 and closes on 31 October 2014.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-28T15:28:25.797Zmore like thismore than 2014-10-28T15:28:25.797Z
star this property question first ministerially corrected
less than 2014-10-28T16:30:53.2329022Zmore like thismore than 2014-10-28T16:30:53.2329022Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property previous answer version
24770
star this property answering member constituency Battersea more like this
star this property answering member printed Jane Ellison more like this
star this property answering member 3918
star this property tabling member
95
unstar this property label Biography information for Mr Andrew Smith more like this
100816
star this property registered interest false more like this
star this property date less than 2014-10-23more like thismore than 2014-10-23
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Terminal Illnesses more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what guidance his Department has issued to health technology appraisal committees on application of NICE's end of life criteria when appraising treatments for patients with terminal illness. more like this
star this property tabling member constituency Redcar more like this
star this property tabling member printed
Ian Swales more like this
star this property uin 211809 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-28more like thisremove minimum value filter
star this property answer text <p>The Department has not issued any such guidance. The National Institute for Health and Care Excellence is an independent body and is responsible for the development of its methods and processes.</p><p> </p> more like this
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-28T14:56:20.6436753Zmore like thismore than 2014-10-28T14:56:20.6436753Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4045
unstar this property label Biography information for Ian Swales more like this
100817
star this property registered interest false more like this
star this property date less than 2014-10-23more like thismore than 2014-10-23
star this property answering body
Department of Health more like this
unstar this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Terminal Illnesses more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health, what rationale lies behind NICE's advice that end-of-life criteria should only apply to medicines that extend life by at least three months. more like this
star this property tabling member constituency Redcar more like this
star this property tabling member printed
Ian Swales more like this
star this property uin 211807 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
unstar this property date of answer less than 2014-10-28more like thisremove minimum value filter
star this property answer text <p>In January 2009, the National Institute for Health and Care Excellence (NICE) issued supplementary advice to its appraisal committees on appraising treatments which may be life-extending for patients, with short life expectancy, and which are licensed for indications affecting small numbers of patients with incurable illnesses.</p><p> </p><p> </p><p> </p><p>This sets out the following three criteria that must all be satisfied for this supplementary advice to be applied:</p><p> </p><p>- the treatment is indicated for patients with a short life expectancy, normally less than 24 months;</p><p> </p><p>- there is sufficient evidence to indicate that the treatment offers an extension to life, normally of at least an additional three months, compared to current NHS treatment; and</p><p> </p><p>- the treatment is licensed or otherwise indicated, for small patient populations.</p><p> </p><p> </p><p> </p><p>These criteria were developed following public consultation and set out the circumstances when NICE considers it is appropriate for its appraisal committees to apply greater flexibility in their appraisal of these treatments.</p><p> </p><p> </p><p> </p><p>The advice has now been incorporated chapter 6 of <em>Guide to the methods of technology appraisal 2013 </em>which can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.nice.org.uk/article/pmg9/chapter/6-the-appraisal-of-the-evidence-and-structured-decision-making" target="_blank">www.nice.org.uk/article/pmg9/chapter/6-the-appraisal-of-the-evidence-and-structured-decision-making</a></p><p> </p><p> </p><p> </p>
star this property answering member constituency Mid Norfolk remove filter
star this property answering member printed George Freeman more like this
star this property question first answered
less than 2014-10-28T14:27:08.2752956Zmore like thismore than 2014-10-28T14:27:08.2752956Z
star this property answering member
4020
star this property label Biography information for George Freeman more like this
star this property tabling member
4045
unstar this property label Biography information for Ian Swales more like this